Statistics
Publications
2
Citations
26
H-Index
2
Active since
2020
Affiliations
WuXi AppTec (China)(Current)
Yuanwu Bao is an author at WuXi AppTec (China) specializing in pharmacology, programmed death-ligand 1 inhibitors, and in vivo efficacy testing.
Publications per year
2020–2020
2
2
CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy
Li Fu, Jingrong Li, Ke Yin et al. · Acta Pharmacologica Sinica · 2020 · 11 citations · Full text
Pharmacy, Immunology, Oncology +16
1–2 of 2